Zum Inhalt springen

Swiss patients face unequal access to life-saving treatment

An investigation by Swiss public television RTS reveals that unequal access to life-saving treatments is growing due to drug launch delays and insurance disparities. With nearly 80,000 applications submitted last year for non-covered medicines, the system presents significant hurdles for patients.

Read the full article at RTS

in News
Big Pharma’s race to stop Alzheimer’s before it starts